scholarly journals VISTA/PD-1H: a potential target for non-small cell lung cancer immunotherapy

2018 ◽  
Vol 10 (12) ◽  
pp. 6378-6382 ◽  
Author(s):  
Juan-Manuel Hernandez-Martinez ◽  
Edgar Vergara ◽  
Zyanya Lucia Zatarain-Barrón ◽  
Feliciano Barrón-Barrón ◽  
Oscar Arrieta
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Immunotherapy ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Potential Target

scholarly journals NLCIPS: Non-Small Cell Lung Cancer Immunotherapy Prognosis Score

2020 ◽  
Vol Volume 12 ◽  
pp. 5975-5985
Author(s):  
Peng Song ◽  
Dongliang Yang ◽  
Xiaoxia Cui ◽  
Hanping Wang ◽  
Xiaoyan Si ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Immunotherapy ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Prognosis Score

scholarly journals Quantifying the benefit of non-small-cell lung cancer immunotherapy – Authors' reply

The Lancet ◽  
2019 ◽  
Vol 394 (10212) ◽  
pp. 1904-1905
Author(s):  
Tony S K Mok ◽  
Jin Zhang ◽  
Gilberto Lopes
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Immunotherapy ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung

Response assessment in non-small cell lung cancer immunotherapy: initial experiences in utilizing FDG PET/CT and the PD-1 blocker nivolumab

2019 ◽  
Vol 12 (2) ◽  
pp. 149-155 ◽  
Author(s):  
Diego Kauffmann-Guerrero ◽  
Andreas Schindler ◽  
Amanda Tufman ◽  
Zulfiya Syunyaeva ◽  
Thomas Pfluger ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Immunotherapy ◽  
Cell Lung Cancer ◽  
Fdg Pet ◽  
Response Assessment ◽  
Small Cell ◽  
Small Cell Lung ◽  
Pet Ct ◽  
Fdg Pet Ct
Sign in / Sign up

Export Citation Format

Share Document